ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 25 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $771,000 | +27.2% | 350,345 | +8.2% | 0.00% | 0.0% |
| Q1 2022 | $606,000 | -14.4% | 323,845 | +0.2% | 0.00% | 0.0% |
| Q4 2021 | $708,000 | -32.2% | 323,345 | +3.5% | 0.00% | 0.0% |
| Q3 2021 | $1,044,000 | -0.2% | 312,545 | -20.2% | 0.00% | 0.0% |
| Q2 2021 | $1,046,000 | -37.8% | 391,629 | -50.2% | 0.00% | -50.0% |
| Q1 2021 | $1,683,000 | +34.5% | 786,606 | +55.3% | 0.00% | +100.0% |
| Q4 2020 | $1,251,000 | +154.8% | 506,389 | +110.3% | 0.00% | – |
| Q3 2020 | $491,000 | +70.5% | 240,841 | +147.2% | 0.00% | – |
| Q2 2020 | $288,000 | +209.7% | 97,446 | +177.6% | 0.00% | – |
| Q1 2020 | $93,000 | -26.2% | 35,103 | +38.7% | 0.00% | – |
| Q4 2019 | $126,000 | +20.0% | 25,300 | +42.9% | 0.00% | – |
| Q3 2019 | $105,000 | – | 17,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eventide Asset Management | 590,602 | $1,577,000 | 0.02% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,020,748 | $2,725,000 | 0.02% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,058 | $62,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 110,000 | $294,000 | 0.01% |
| Alberta Investment Management Corp | 130,000 | $347,000 | 0.00% |
| Jaffetilchin Investment Partners, LLC | 11,000 | $29,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 164,229 | $438,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 162,942 | $435,000 | 0.00% |
| Janney Montgomery Scott LLC | 69,487 | $186,000 | 0.00% |
| Renaissance Technologies | 391,629 | $1,046,000 | 0.00% |